Technische Universität Dresden, Institute of Clinical Psychology and Psychotherapy.
Technische Universität Dresden, Institute of Clinical Psychology and Psychotherapy; University of Applied Sciences for Social Work, Education and Nursing.
Behav Ther. 2023 May;54(3):427-443. doi: 10.1016/j.beth.2022.11.001. Epub 2022 Nov 9.
Despite striking empirical support, exposure-based treatments for anxiety disorders are underutilized. This is partially due to clinicians' concerns that patients may reject exposure or experience severe side effects, particularly in intensive forms of exposure. We examined acceptance and side effects of two randomly assigned variants of prediction error-based exposure treatment differing in temporal density (1 vs. 3 sessions/week) in 681 patients with panic disorder, agoraphobia, social anxiety disorder, and multiple specific phobias. Treatment acceptance included treatment satisfaction and credibility, engagement (i.e., homework completion), and tolerability (i.e., side effects, dropout, and perceived treatment burden). Side effects were measured with the Inventory for the Balanced Assessment of Negative Effects of Psychotherapy (INEP). We found treatment satisfaction, credibility, and engagement to be equally high in both variants of exposure-based treatment, despite higher treatment burden (β = 0.25) and stronger side effects (β = 0.15) in intensified treatment. 94.1% of patients reported positive effects in the INEP. 42.2% reported side effects, with treatment stigma (16.6%), low mood (14.8%) and the experience to depend on the therapist (10.9%) being the most frequently reported. The mean intensity of side effects was low. We conclude that prediction error-based exposure treatment is well accepted by patients with different anxiety disorders and that patients also tolerate temporally intensified treatment, despite higher perceived treatment burden and stronger side effects. Clinicians should be aware of the most frequent side effects to take appropriate countermeasures. In sum, temporal intensification appears to be an acceptable strategy to achieve faster symptom reduction, given patients' well-informed consent.
尽管有确凿的实证支持,但焦虑障碍的暴露疗法的应用仍不充分。这部分是由于临床医生担心患者可能会拒绝暴露或经历严重的副作用,尤其是在强化暴露形式中。我们在 681 名患有惊恐障碍、广场恐惧症、社交焦虑症和多种特定恐惧症的患者中,检查了两种基于预测误差的暴露治疗方法的随机分配变体(每周 1 次与 3 次)的接受度和副作用,这两种变体在时间密度上有所不同。治疗接受度包括治疗满意度和可信度、参与度(即家庭作业完成情况)和耐受性(即副作用、脱落和感知的治疗负担)。副作用使用心理治疗的平衡负面效应评估量表(INEP)进行测量。我们发现,尽管强化治疗的治疗负担(β=0.25)和副作用(β=0.15)更强,但两种基于暴露的治疗方法的治疗满意度、可信度和参与度都同样高。94.1%的患者报告 INEP 有积极效果。42.2%的患者报告有副作用,其中治疗污名化(16.6%)、情绪低落(14.8%)和依赖治疗师的体验(10.9%)是最常报告的副作用。副作用的平均强度较低。我们得出结论,基于预测误差的暴露治疗被不同焦虑障碍的患者所接受,并且患者也能耐受时间强化治疗,尽管治疗负担感知更高,副作用更强。临床医生应该意识到最常见的副作用,以便采取适当的对策。总之,鉴于患者知情同意,时间强化似乎是一种可接受的策略,可以更快地减轻症状。